Cancer Search logoCancer Search
  1. Home
  2. Cancer Therapies
  3. 8 PD-L1 Expression (CPS >= 1) Cancer Therapies

PD-L1 Expression (CPS >= 1)
{name}
{subtitle}
pembrolizumab + chemotherapy +/- bevacizumab
biomarker
PD-L1 Expression (CPS >= 1)
condition
Cervical Carcinoma
disease state
Metastatic, +1 more state
drug
bevacizumab, +2 more drugs
drug type
chemotherapy, +2 more types
FDA Approval
link 62565
2021-10-13
pembrolizumab
biomarker
PD-L1 Expression (CPS >= 1)
condition
Head and Neck Squamous Cell Carcinoma
disease state
Metastatic, +2 more states
therapeutic contexts
First line
drug
pembrolizumab
drug type
immunotherapy
FDA Approval
link 54813
2019-06-17
pembrolizumab
biomarker
PD-L1 Expression (CPS >= 1)
condition
Cervical Carcinoma
disease state
Metastatic, +1 more state
therapeutic contexts
Subsequent line
drug
pembrolizumab
drug type
immunotherapy
FDA Approval
link 54995
2018-06-13
nivolumab
biomarker
PD-L1 Expression (CPS >= 1)
condition
Cervical Carcinoma
disease state
Metastatic, +1 more state
therapeutic contexts
Subsequent line
drug
nivolumab
drug type
immunotherapy
NCCN Guideline
link 62632
2A
pembrolizumab
biomarker
PD-L1 Expression (CPS >= 1)
condition
Cervical Carcinoma
disease state
Metastatic, +1 more state
therapeutic contexts
Subsequent line
drug
pembrolizumab
drug type
immunotherapy
NCCN Guideline
link 55163
2A
pembrolizumab
biomarker
PD-L1 Expression (CPS >= 1)
condition
Vulvar Squamous Cell Carcinoma
disease state
Advanced, +2 more states
therapeutic contexts
Second line
drug
pembrolizumab
drug type
immunotherapy
NCCN Guideline
link 55288
2A
pembrolizumab + paclitaxel + (carboplatin or cisplatin) +/- bevacizumab
biomarker
PD-L1 Expression (CPS >= 1)
condition
Cervical Carcinoma
disease state
Metastatic, +1 more state
therapeutic contexts
First line
drug
bevacizumab, +4 more drugs
drug type
chemotherapy, +2 more types
NCCN Guideline
link 62630
1
MT-6402
biomarker
PD-L1 Expression (CPS >= 1), +4 more biomarkers
condition
Non-Small Cell Lung Carcinoma
disease state
Advanced
drug
MT-6402
drug type
immunotherapy
FDA Fast Track
link 62702
2021-11-18
8 Items
Page 1 of 1
Main Menu
Clinical Trials
Therapies
Biomarkers
Cancer Types
Drugs
About
Cancer Search
Terms
Site Map
Credits
FAQ
Powered By
GenomOncology, LLC Logo
Copyright © 2022 GenomOncology, LLC